1.
Bibliography
Solomon, A. An unusual receptive aphasia as a manifestation of temporal-lobe epilepsy. Report of a case treated by surgery. N. Engl. J. Med . 257 :313-317, 1957.
2. Solomon, A. and Kuhn, L.A. Postural hypotension: Report of a case, with hemodynamic studies of central, peripheral, and pulmonary artery pressures. Am. J. Med . 28 :328-332, 1960.
3. Fudenberg, H. and Solomon, A. "Acquired agammaglobulinemia" with auto-immune hemolytic disease: Graft-versus-host reaction? Vox Sang. 6 :68-79, 1961.
4. Solomon, A. The effect of urine hydrolysis on nucleoproteins in normal, leukemoid, and leukemic leukocytes. J. Mt. Sinai Hosp. NY. 28 :435-443, 1961.
5. Cline, M.J., Solomon, A., Berlin, N.I., and Fahey, J.L. Anemia in macroglobulinemia. Am. J.
Med.
34 :213-220, 1963.
6. Cohen, S., Solomon, A., Paronetto, F., and Popper, H. Subacute hepatitis in Waldenström's macroglobulinemia. Am. J. Med.
34 :256-263, 1963.
7. Solomon, A., Fahey, J.L., and Malmgren, R.A. Immunohistologic localization of gamma-l- macroglobulins, beta-2A-myeloma proteins, 6.6S gamma-myeloma proteins, and Bence Jones proteins. Blood.
21 :403-423, 1963.
8. Solomon, A. and Fahey, J.L. Plasmapheresis therapy in macroglobulinemia. Ann. Intern Med.
58 :789-800, 1963.
9. Fahey, J.L. and Solomon, A. Two types of

-myeloma proteins,

2A
-myeloma proteins,

1
-macro globulins, and Bence Jones proteins identified by two groups of common antigenic determinants.
J. Clin. Invest. 42 :811-822, 1963.
10. Solomon, A., Waldmann, T.A., and Fahey, J.L. Metabolism of normal 6.6S

-globulin in normal subjects and in patients with macroglobulinemia and multiple myeloma. J. Lab. Clin. Med. 62 :1-
17, 1963.
11. Solomon, A. Waldmann, T.A., Fahey, J.L., and McFarlane, A.S. Metabolism of Bence Jones proteins. J. Clin. Invest.
43 :103-117, 1964.
12. Gill, J.R., Jr., George, J.M., Solomon, A., and Bartter, F.C. Hyperaldosteronism and renal sodium loss reversed by drug treatment for malignant hypertension. N Eng J Med 27 :1088-1092, 1964.
13.
Solomon, A. and Fahey, J.L. Bence Jones proteinemia. Am. J. Med. 37 :206-222, 1964.
14. Tomasi, T.B., Jr., Tan, E.M., Solomon, A., and Prendergast, R.A. Characteristics of an immune system common to certain external secretions. J. Exp. Med. 121 :101-124, 1965.
15. Solomon, A. Neurological manifestations of macroglobulinemia. In The Remote Effects of
Cancer on the Nervous System. Brain, L. and Norris, F.H., Jr., Eds., Grune & Stratton, New York,
20

1965, pp. 112-124.
16. Fahey, J.L., Barth, W.F., and Solomon, A. Serum hyperviscosity syndrome. J. Am. Med. Assoc.
192 :464-467, 1965.
17. Solomon, A., Killander, J., Grey, H.M., and Kunkel, H.G. Low-molecular-weight proteins related to Bence Jones proteins in multiple myeloma. Science . 151 :1237-1239, 1966.
18. Kunkel, H.G., Grey, H.M., and Solomon, A. Antigenic variations among myeloma proteins and antibodies. In Immunopathology. IVth International Symposium. Grabar, P. and Miescher, P.A.,
Eds., Grune & Stratton, New York, 1966, pp. 220-228.
19. Zak, F.G., Solomon, A., and Fellner, M.J. Viscero-cutaneous angiomatosis with dysproteinaemic phagocytosis: Its relation to Kaposi's sarcoma and lymphoproliferative disorders. J. Pathol.
Bacteriol. 92 :594-599, 1966.
20. Rubin, H. and Solomon, A. Cold agglutinins of anti-i specificity in alcoholic cirrhosis. Vox Sang.
12 :227-230, 1967.
21. Solomon, A. and Kunkel, H.G. A "monoclonal" type, low molecular weight protein related to

M- macroglobulins. Am. J. Med. 42 :958-967, 1967.
22. Caggiano, V., Cuttner, J., and Solomon, A. Myeloma proteins, Bence Jones proteins and normal immunoglobulins in multiple myeloma. Blood. 30 :265-287, 1967.
23. Solomon, A. Molecular heterogeneity of immunoglobulin-M (

M-globulin). J. Immunol.
102 :496-506, 1969.
24. Solomon, A. and McLaughlin, C.L. Bence-Jones proteins and light chains of immunoglobulins. I.
Formation and characterization of amino-terminal (variant) and carboxyl-terminal (constant) halves. J. Biol. Chem.
244 :3393-3404, 1969.
25. Solomon, A. and McLaughlin, C.L. Bence Jones proteins and light chains of immunoglobulins.
II. Immunochemical differentiation and classification of kappa-chains. J. Exp. Med. 130 :1295-
1311, 1969.
26. Solomon, A. and McLaughlin, C.L. Biosynthesis of low molecular weight (7S) and high molecular weight (19S) immunoglobulin M. J. Clin. Invest. 49 :150-160, 1970.
27. Buonocore, E., Solomon, A., and Kerley, H.E. Pseudomyeloma. Radiology. 95 :41-46, 1970.
28. Solomon, A. Bence Jones protein: A molecular entity for studies on the structural and genetic control of antibody specificity. J.
Mt. Sinai Med.
37 :466-476, 1970 (Festschrift for Dr. Alexander
B. Gutman).
29. Solomon, A., McLaughlin, C.L., and Steinberg, A.G. Bence Jones proteins and light chains of immunoglobulins. III. Inv antigenicity: A genetic expression with serologic dependency on the
21

intact kappa light chain molecule. Immunochemistry.
7 :709-713, 1970.
30. Solomon, A. and McLaughlin, C.L. Bence Jones proteins and light chains of immunoglobulins.
IV. Immunochemical differentiation among proteins within each of the three established

-chain classes. J. Immunol.
106 :120-127, 1971.
31.
Solomon, A., McLaughlin, C.L., Wei, C.H., and Einstein, J.R. Bence-Jones proteins and light chains of immunoglobulins. V. X-ray crystallographic investigation of the amino-terminal half of a

Bence-Jones protein. J. Biol. Chem.
245 :5289-5291, 1970.
32. McLaughlin, C.L. and Solomon, A. Bence Jones proteins and light chains of immunoglobulins.
VI. Immunochemical detection of interclass similarities among

-chains. J. Immunol. 107 :1699-
1705, 1971.
33. Rush, E.A., McLaughlin, C.L., and Solomon, A. The essentiality of decyclization of pyrrolidone- carboxylic acid prior to utilization in protein biosynthesis. Cancer Res.
31 :1134-1139, 1971.
34. McLaughlin, C.L. and Solomon, A. Bence-Jones proteins and light chains of immunoglobulins.
VII. Localization of antigenic sites responsible for immunochemical heterogeneity of

chains. J.
Biol. Chem. 247 :5017-5025, 1972.
35. Solomon, A. and McLaughlin, C.L. Immunoglobulin structure determined from products of plasma cell neoplasms. Semin. Hematol.
10 :3-17, 1973.
36. Solomon, A. and McLaughlin, C.L. Immunoglobulin disturbances and their clinical significance.
Med. Clin. North Am.
57 :499-516, 1973.
37. McLaughlin, C.L. and Solomon, A. A hidden antigenic site localized to the constant region of light chains of immunoglobulins. Science . 179 :580-582, 1973.
38. Grey, H.M., Colon, S., Solomon, A., and McLaughlin, C.L. Immunoglobulin on the surface of human lymphocytes. The detection of kappa chain V region determinants on B cells and not on T cells. J. Immunol.
111 :1923-1925, 1973.
39. Milstein, C.P., Steinberg, A.G., McLaughlin, C.L., and Solomon, A. Amino acid sequence change associated with genetic marker Inv(2) of human immunoglobulin. Nature. 248 :160-161, 1974.
40. Steinberg, A.G., Milstein, C.P., McLaughlin, C.L., and Solomon, A. Structural studies of an
Inv(1,-2) kappa light chain. Immunogenetics . 1 :108-117, 1974.
41. Vodopick, H., Chaskes, S.J., Solomon, A., and Stewart, J.A. Transient monoclonal gammopathy associated with cytomegalovirus infection. Blood . 44 :189-195, 1974.
42. McLaughlin, C.L. and Solomon, A. Immunochemical classification of nonisolated light chains of immunoglobulins. J. Immunol.
113 :1369-1372, 1974.
43. Solomon, A., McLaughlin, C.L., and Capra, J.D. Bence Jones proteins and light chains of
22

immunoglobulins. XI. A transient Bence Jones-related protein associated with corticosteroid therapy. J. Clin. Invest.
55 :579-586, 1975.
44. Solomon, A. Cellular regulation of humoral immunity (editorial). N. Engl. J. Med.293 :928-929,
1975.
45. Solomon, A. Medical progress: Bence-Jones proteins and light chains of immunoglobulins. Parts
I and II. N. Engl. J. Med. 294 :17-23, 91-98, 1976.
46. Solomon, A., Sonoda, T., and Patterson, F.K. Response of metastatic malignant carcinoid tumor to adriamycin (NSC-123127). Cancer Treat. Rep. 60 :273-276, 1976.
47. Sonoda, T., Solomon, A., Krauss, S., Cruz, P., Jones, F.S., and Levin, J. Use of prothrombin complex concentrates in the treatment of a hemophilic patient with an inhibitor of factor VIII.
Blood . 47 :983-989, 1976.
48. Longworth, J.W., McLaughlin, C.L., and Solomon, A. Luminescence studies on Bence Jones proteins and light chains of immunoglobulins and their subunits. Biochemistry . 15 :2953-2958,
1976.
49. Solomon, A., Schmidt, W., and Havemann, K. Bence Jones proteins and light chains of immunoglobulins. XIII. Effect of elastase-like and chymotrypsin-like neutral proteases derived from human granulocytes on Bence Jones proteins. J. Immunol. 117 :1010-1014, 1976.
50. Solomon, A. Bence Jones proteins and light chains of immunoglobulins. XIV. Conformational dependency and molecular localization of the kappa (

) and lambda (

) antigenic determinants.
Scand. J. Immunol.
5 :685-695, 1976.
51. Feizi, T., Lecomte, J., Childs, R., and Solomon, A. Kappa chain (V 
III
) subgroup-related activity in an idiotypic anti-cold agglutinin serum. Scand. J. Immunol. 5 :629-636, 1976.
52. Solomon, A. Bence Jones proteins and light chain fragments: Biochemical and clinical studies.
In Topics in Hematology. Seno, S., Takaku, F., and Irino, S., Eds., Excerpta Medica, Amsterdam,
1976, pp. 451-453.
53. Tornyos, K., Silberman, H., and Solomon, A. Phase II study of oral methyl-CCNU and prednisone in previously treated alkylating agent-resistant multiple myeloma. Cancer Treat. Rep.
61 :785-787, 1977.
54. Solomon, A. Homogeneous (monoclonal) immunoglobulins in cancer (editorial). Am. J. Med.
63 :169-176, 1977.
55. Hübner, K.F., Andrews, G.A., Hayes, R.L., Poggenburg, J.K., and Solomon, A. The use of rareearth radionuclides and other bone-seekers in the evaluation of bone lesions in patients with multiple myeloma or solitary plasmacytoma. Radiology. 125 :171-176, 1977.
56. Solomon, A. Bence Jones proteins and light chains of immunoglobulins. XVI. Immunochemical
23

recognition of the human lambda light-chain constant-region isotype Mcg. Immunogenetics.
5 :525-533, 1977.
57. Solomon, A. Detection of chemotherapeutic-associated alterations of monoclonal and polyclonal immunoglobulins in multiple myeloma. In Current Chemotherapy. Siegenthaler, W. and Luthy,
R., Eds., Vol. 2, American Society for Microbiology, Washington, D.C., 1977, pp. 1108-1110.
58. Solomon, A. Bence Jones proteins and light chains of immunoglobulins. XV. Effect of corticosteroids on synthesis and excretion of Bence Jones protein. J. Clin. Invest.
61 :97-108,
1978.
59. Solomon, A. M proteins in cancer (Reply: Letter to the Editor). Am. J. Med.
64 :1089-1090, 1978.
60.
Solomon, A. Possible role of PMN proteases in immunoglobulin degradation and amyloid formation. In Neutral Proteases of Human Polymorphonuclear Leukocytes. Havemann, K. and
Janoff, A., Eds., Urban & Schwarzenberg, Baltimore, 1978, pp. 423-438.
61. Solomon, A. and Havemann, K. Bence Jones proteins and light chains of immunoglobulins.
XVII. Unique susceptibility of certain

-chains to proteolysis by human granulocyte-derived neutral proteases. Immunochemistry.
15 :453-458, 1978.
62. Schiffer, M., Westholm, F.A., Panagiotopoulos, N., and Solomon, A. Crystallographic data on a complete

-type human Bence-Jones protein. J. Mol. Biol.
124 :287-290, 1978.
63. Solomon, A., Gramse, M., and Havemann, K. Proteolytic cleavage of human IgG molecules by neutral proteases of polymorphonuclear leukocytes. Eur. J. Immunol.
8 :782-785, 1978.
64. Krauss, S., Tornyos, K., DeSimone, P., Lowenbraun, S., McKeown, J., Solomon, A., and Sonoda,
T. cis-Dichlorodiammineplatinum(II) and hexamethylmelamine in the treatment of non-oat cell lung cancer: A pilot study of the Southeastern Cancer Study Group. Cancer Treat. Rep. 63 :391-
393, 1979.
65. Krauss, S., Sonoda, T., and Solomon, A. Treatment of advanced gastrointestinal cancer with 5- fluorouracil and mitomycin C. Cancer. 43 :1598-1603, 1979.
66. Solomon, A. Monoclonal immunoglobulins as biomarkers of cancer. In Cancer Markers:
Developmental and Diagnostic Significance. Sell, S., Ed., Humana Press, Clifton, New Jersey,
1980, pp. 57-87.
67. Stevens, F.J., Westholm, F.A., Solomon, A., and Schiffer, M. Self-association of human immuno- globulin

I light chains: Role of the third hypervariable region. Proc. Natl. Acad. Sci. USA.
77 :1144-1148, 1980.
68. Kosaka, M. and Solomon, A. Hyperviscosity syndrome associated with an idiopathic monoclonal
IgA-rheumatoid factor. Am. J. Med. 69 :145-154, 1980.
69. Solomon, A. Current developments in immunoglobulins. In Contemporary
24

Hematology/Oncology, Silber, R., Gordon, A.S., LoBue, J. and Muggia, F.M., Eds., Vol. 2, 1981, pp. 399-465.
70. Levy, D.E., Horner, A.A., and Solomon, A. Immunoglobulin-sulfated polysaccharide interactions.
The binding of agaropectin and heparin by human IgG proteins. J. Exp. Med. 153 :883-896, 1981.
71. Whitson, M.E., Griffin, G.D., Novelli, G.D., and Solomon, A. In vitro sensitization of human lymphocytes to a myeloma cell-related antigen. Cell Immunol.
60 :489-497, 1981.
72. Stevens, F.J., Westholm, F.A., Panagiotopoulos, N., Schiffer, M., Popp, R.A., and Solomon, A.
Characterization and preliminary crystallographic data on the V
L
-related fragment of the human

I
Bence Jones protein Wat. J. Mol. Biol. 147 :185-193, 1981.
73. Stevens, F.J., Westholm, F.A., Panagiotopoulos, N., Solomon, A., and Schiffer, M. Preliminary crystallographic data on the human

III Bence Jones protein dimer Cle. J. Mol. Biol. 147 :179-
183, 1981.
74. Solomon, A. Bence Jones proteins: Malignant or benign? (editorial). N. Engl. J. Med. 306 :605-
607, 1982.
75. Solomon, A., Frangione, B., and Franklin, E.C. Bence Jones proteins and light chains of immunoglobulins. Preferential association of the V 
VI
subgroup of human light chains with amyloidosis AL(

). J. Clin. Invest.
70 :453-460, 1982.
76. Koopman, W.J., Schrohenloher, R.E., and Solomon, A. A quantitative assay for IgA rheumatoidfactor. J. Immunol. Methods. 50 :89-98, 1982.
77. Griffin, G.D., Owen, B.A., Atchley, C.E., Novelli, G.D., and Solomon, A. Decreased immunoglobulin production by a human lymphoid cell line following melphalan treatment.
Cancer Res.
42 :4505-4510, 1982.
78. Ledford, D.K., Goñi, F., Pizzolato, M., Franklin, E.C., Solomon, A., and Frangione, B.
Preferential association of

IIIb light chains with monoclonal human IgM

auto-antibodies. J.
Immunol.
131 : 1322-1325, 1983.
79. Frangione, B., Moloshok, T., and Solomon, A. Primary structure of the variable region of a human

VI light chain: Bence Jones protein SUT. J. Immunol.
131 :2490-2493, 1983.
80. Greenstein, J.L., Solomon, A., and Abraham, G.N. Monoclonal antibodies reactive with idiotypicand variable-region specific determinants on human immunoglobulins. Immunology.
51 :17-25, 1984.
81. Klöbeck, H.-G., Solomon, A., and Zachau, H.G. Contribution of human V

II
germ-line genes to light-chain diversity. Nature. 30 9:73-76, 1984.
82. Pons-Estel, B., Goñi, F., Solomon, A., and Frangione, B. Sequence similarities among

IIIb chains of monoclonal human IgM

autoantibodies. J. Exp. Med.
160 :893-904, 1984.
25

83. Solomon, A. Light chains of human immunoglobulins. Methods Enzymol.
116 :101-121, 1985.
84. Schrohenloher, R.E., Koopman, W.J., Moldoveanu, Z., and Solomon, A. Activity of rheumatoid factors of different molecular sizes: Comparison of autologous monomeric and polymeric monoclonal IgA rheumatoid factors. J. Immunol.
134 :1469-1474, 1985.
85. Frangione, B., Moloshok, T., Prelli, F., and Solomon, A. Human

light-chain constant region gene C
 Mor
: The primary structure of

VI Bence Jones protein Mor. Proc. Natl. Acad. Sci. USA.
82 :3415-3419, 1985.
86. Klobeck, H.-G., Meindl, A., Combriato, G., Solomon, A., and Zachau, H.G. Human immunoglobulin kappa light chain genes of subgroups II and III. Nucleic Acids Res.
13 :6499-
6513, 1985.
87. Chang, C-H., Short, M.T., Westholm, F.A., Stevens, F.J., Wang, B-C., Furey, W., Jr., Solomon,
A., and Schiffer, M. Novel arrangement of immunoglobulin variable domains: X-ray crystallographic analysis of the

-chain dimer Bence-Jones protein Loc. Biochemistry. 24 :4890-
4897, 1985.
88. Ghiso, J., Solomon, A., and Frangione, B. Association of human

light chain V/J/C segments:Serologic analysis and primary structure of the

VI Bence Jones protein THO. J.
Immunol. 136 : 716-719, 1986.
89. Solomon, A., Kyle, R.A., and Frangione, B. Light chain variable region subgroups of monoclonal immunoglobulins in amyloidosis AL. In Amyloidosis. G.G. Glenner, E.F.
Osserman, E.P. Benditt, E. Calkins, A.S. Cohen, and D. Zucker-Franklin, Eds., Plenum Press,
New York, 1986, pp. 449-462.
90. Solomon, A. Clinical implications of monoclonal light chains. Semin. Oncol.
13 :341-349, 1986.
91. Prelli, F., Tummolo, D., Solomon, A., and Frangione, B. Novel human light chain V  segment:
Serological and structural analyses of the

III-like Bence Jones protein and IgG

light chain REE.
J. Immunol.
136 :4169-4173, 1986.
92. Solomon, A. Light chains of immunoglobulins: Structural-genetic correlates. Blood . 68 :603-
610, 1986.
93. Walker, M.R., Solomon, A., Ling, N.R., Brown, B., Lowe, J.A., Hardie, D., and Jefferis, R.
Immunogenic and antigenic epitopes of immunoglobulins. XVIII. Subpopulations of human lambda chains defined with a panel of monoclonal antibodies. Immunology.
59 :467-471, 1986.
94. Silverman, G.J., Carson, D.A., Solomon, A., and Fong, S. Human kappa light chain subgroup analysis with synthetic peptide-induced antisera. J. Immunol. Methods.
95 :249-257, 1986.
95. Davidson, A., Preud'homme, J-L., Solomon, A., Chang, M-D.Y., Beede, S., and Diamond, B.
Idiotypic analysis of myeloma proteins: anti-DNA activity of monoclonal immunoglobulins
26

bearing an SLE idiotype is more common in IgG than IgM antibodies. J. Immunol.
138 :1515-
1518, 1987.
96. Solomon, A. and Weiss, D.T. Serologically defined V region subgroups of human

light chains.
J. Immunol.
139 :824-830, 1987.
97. Livneh, A., Preud'homme, J-L., Solomon, A., and Diamond, B. Preferential expression of the systemic lupus erythematosus-associated idiotype 8.12 in sera containing monoclonal immunoglobulins. J. Immunol.
139 :3730-3733, 1987.
98. Solomon, A. and Weiss, D.T. A perspective of plasma cell dyscrasias: Clinical implications of monoclonal light chains in renal disease. In The Kidney in Plasma Cell Dyscrasias. L. Minetti, G.
D'Amico, and C. Ponticelli, Eds., Kluwer Academic Publishers, Dordrecht, The Netherlands,
1988, pp. 3-18.
99. Walker, M.R., Solomon, A., Weiss, D.T., Deutsch, H.F., and Jefferis, R. Immunogenic and antigenic epitopes of Ig. XXV. Monoclonal antibodies that differentiate the Mcg +
Oz
+
/Oz
-
C region isotypes of human

L chains. J. Immunol.
140 :1600-1604, 1988.
/Mcg - and
100. Goñi, F.R., Chen, P.P., McGinnis,D., Arjonilla, M.L., Fernandez, J., Carson, D., Solomon, A.,
Mendez, E., and Frangione, B. Structural and idiotypic characterization of the L chains of human
IgM autoantibodies with different specificities. J. Immunol.
142 :3158-3163, 1989.
101. Schiffer, M., Ainsworth, C., Xu, Z.-B., Carperos, W., Olsen, K., Solomon, A., Stevens, F.J., and
Chang, C.-H. Structure of a second crystal form of Bence-Jones protein Loc: Strikingly differentdomain associations in two crystal forms of a single protein. Biochemistry . 28 :4066-
4072, 1989.
102. Davidson, A., Smith, A., Katz, J., Preud'homme, J-L., Solomon, A., and Diamond, B. A crossreactive idiotype on anti-DNA antibodies defines a H chain determinant present almost exclusively on IgG antibodies. J. Immunol.
143 :174-180, 1989.
103. Arsen'eva, E.L., Bogacheva, G.T., Solomon, A., and Rokhlin, O.V. Antigen determinants on human immunoglobulin

chain constant domains detected by monoclonal antibodies. Mol.
Biol.23 :1227-1233, 1989.
104. Arsen'eva, E.L., Bogacheva, G.T., Solomon, A., Weiss, D.T., and Rokhlin, O.V. Analysis of human immunoglobulin

light chain antigenic structure using monoclonal antibodies. Mol.
Biol.24 :101-109, 1990.
105. Buxbaum, J.N., Chuba, J.V., Hellman, G.C., Solomon, A., and Gallo, G.R. Monoclonal immuno- globulin deposition disease: Light chain and heavy chain deposition diseases and their relation to light chain amyloidosis. Ann. Intern. Med. 112 :455-464, 1990.
106. Eulitz, M., Weiss, D.T., and Solomon, A. Immunoglobulin heavy-chain-associated amyloidosis.
Proc. Natl. Acad. Sci. USA. 87 :6542-6546, 1990.
27

107. Solomon, A., Weiss, D.T., Macy, S.D., and Antonucci, R.A. Immunocytochemical detection of kappa and lambda light chain V region subgroups in human B cell malignancies. Am. J. Pathol.
137 :855-862, 1990.
108. Caudle, M.R., Dodd, S., and Solomon, A. Multiple myeloma in pregnancy: A case report.
ObstetGynecol. 75 :516-518, 1990.
109. Solomon, A. and Weiss, D.T. Experimental production of human amyloidosis AL. In Amyloid and Amyloidosis 1990. J.B. Natvig, O,/. Fo,/rre, G. Husby, A. Husebekk, B. Skogen, K. Sletten, and P. Westermark, Eds., Kluwer Academic Publishers, Dordrecht, The Netherlands, 1991, pp.
193-196.
110. Eulitz, M., Breuer, M., Eblen, A., Weiss, D.T., and Solomon, A. Production of amyloidogenicpeptides from human immunoglobulin light (L)-chains. In Amyloid and
Amyloidosis 1990. J.B. Natvig, O,/. Fo,/rre, G. Husby, A. Husebekk, B. Skogen, K. Sletten, and
P. Westermark, Eds., Kluwer Academic Publishers, Dordrecht, The Netherlands, 1991, pp. 505-
510.
111. Silvestris, F., Rots, N., Yancey, W., Jr., Malone, C., Searles, R., Solomon, A., and Williams, R.C.,
Jr. Monoclonal antibodies against human anti-F(ab')
2
antibodies react with light chain epitopes.
Clin. Immunol. Immunopathol. 59 :139-155, 1991.
112. Eulitz, M., Murphy, C., Weiss, D.T., and Solomon, A. Serological and chemical differentiation of human

III light chain variable regions. J. Immunol.
146 :3091-3096, 1991.
113. Solomon, A., Weiss, D.T., and Kattine, A.A. Nephrotoxic potential of Bence Jones proteins. N.
Engl. J. Med. 324 :1845-1851, 1991.
114. Stevens, F.J., Solomon, A., and Schiffer, M. Bence Jones Proteins: A powerful tool for the fundamental study of protein chemistry and pathophysiology. Biochemistry. 30 :6803-6805, 1991.
115. Solomon, A., Weiss, D.T., and Pepys, M.B. Induction in mice of human light-chain-associated amyloidosis (AL amyloidosis). Am. J. Pathol.
140 :629-637, 1992.
116. Nilson, B., Solomon, A., Björck, L., and Åkerström, B. Protein L from peptostreptococcus magnus binds to the kappa light chain variable domain. J. Biol. Chem. 267 :2234-2239, 1992.
117. Kanangat, S., Solomon, A., and Rouse, B.T. Use of quantitative polymerase chain reaction to quantitate cytokine messenger RNA molecules. Mol. Immunol.
29: 1229-1236, 1992.
118. Daniel, S.L., Brenner, C.A., Legendre, A.M., Solomon, A., and Rouse, B.T. Feline cytokines
TNF

and IL-1

: PCR cloning and sequencing of cDNA. Anim. Biotechnol. 3 :281-297, 1992.
119. Solomon, A., Weiss, D.T., and Williams, T.K. Experimental model of human light-chainassociated disease. Curr. Top. Microbiol. Immunol.
182 :261-267, 1992.
120. Williams, R., Malone, C., and Solomon, A. Conformational dependency of human IgG heavy-
28

chain-associated Gm allotypes. Mol. Immunol.
30 :341-351, 1993.
121. Abe, M., Goto, T., Kennel, S.J., Wolfenbarger, D., Macy, S.D., Weiss, D.T., and Solomon, A.
Production and immunodiagnostic applications of anti-human light chain monoclonal antibodies.
Am. J. Clin. Pathol.
100 :67-74, 1993.
122. Abe, M., Goto, T., Wolfenbarger, D., Weiss, D.T., and Solomon, A. Novel immunization protocol and ELISA screening methods used to obtain and characterize monoclonal antibodies specific for human light chain variable-region subgroups. Hybridoma.
12 :475-483, 1993.
123. Solomon, A. and Weiss, D.T. Ominous consequences of immunoglobulin deposition. N. Engl. J.
Med.
329 :1422-1424, 1993.
124. Solomon, A., Weiss, D.T., and Murphy, C. Primary amyloidosis associated with a novel heavychain fragment (AH amyloidosis). Am. J. Hematol.
45 :171-176, 1994.
125. Abe, M., Ozaki, S., Wolfenbarger, D., deBram-Hart, M., Weiss, D.T., and Solomon, A. Variableregion subgroup distribution among

-type immunoglobulins in normal human serum. J. Clin.
Lab. Anal. 8 :4-9, 1994.
126. Solomon, A. and Weiss, D.T. AL amyloidosis. In Amyloid and Amyloidosis 1993. R.
Kisilevsky, M. Benson, B. Frangione, J. Gauldie, T. Muckle, and I. Young, Eds., Parthenon
Publishing, New York, 1994, pp. 200-205.
127. Solomon, A., Weiss, D.T., and Murphy, C. Heavy-chain-associated amyloidosis (AH amyloidosis). In Amyloid and Amyloidosis 1993. R. Kisilevsky, M. Benson, B. Frangione, J.
Gauldie, T. Muckle, and I. Young, Eds., Parthenon Publishing, New York, 1994, pp. 212-214.
128. Ozaki, S., Abe, M., Wolfenbarger, D., , D.T, and Solomon, A. Preferential expression of human

-light-chain variable-region subgroups in multiple myeloma, AL amyloidosis, and Waldenström's macroglobulinemia.
Clin. Immunol. Immunopathol.
71 :183-189, 1994.
129. Fang, Q., Kannapell, C.C., Gaskin, F., Solomon, A., Koopman, W.J., and Fu, S.M. Human rheumatoid factors with restrictive specificity for rabbit IgG: Auto- and multi-reactivity, diverse
V
H
gene segment usage and preferential usage of V 
IIIb
. J. Exp. Med. 179 :1445-1456, 1994.
130. Ch'ang, L-Y., Yen, C-P., Besl, L., Schell, M., and Solomon, A. Identification and characterization of a functional human Ig V 
VI
germline gene. Mol. Immunol. 31 :531-536, 1994.
131. Myatt, E.A., Westholm, F.A., Weiss, D.T., Solomon, A., Schiffer, M., and Stevens, F.J.
Pathogenic potential of human monoclonal immunoglobulin light chains: Relationship of in vitro aggregation to in vivo organ deposition. Proc. Natl. Acad. Sci. USA. 91 :3034-3038, 1994.
132. Ermel, R.W., Kenny, T.R., Wong, A., Solomon, A., Chen, P.P., and Robbins, D.L. Preferential utilization of a novel V

3 gene in monoclonal rheumatoid factors derived from the synovial cells of rheumatoid arthritis patients. Arthritis Rheum. 37 :860-868, 1994.
29

133. Abe, M., Goto, T., Ozaki, S., Kosaka, M., and Solomon, A. Enzyme-linked immunosorbent assay for variable region

VI subgroup of light chain in serum: Method and results in normal subjects and patients with hyper- and hypogammaglobulinemia. Japanese J. Clin. Immunol.
17 :172-181,
1994.
134. Solomon, A., Weiss, D.T., Murphy, C., Fu, S.M., and Robbins, D.L. Chemical and serologic characterization of human

VIII light chains. J. Immunol.
153 :1658-1664, 1994.
135. Goto, T., Kennel, S.J., Abe, M., Takishita, M., Kosaka, M., Solomon, A., and Saito, S. A novel membrane antigen selectively expressed on terminally- differentiated human B cells. Blood .
84 :1922-1930, 1994.
136. Ozaki, S., Wolfenbarger, D., deBram-Hart, M., Kanangat, S., Weiss, D.T., and Solomon, A.
Characterization of a novel interleukin-6 autocrine-dependent human plasma cell line. Leukemia.
8 :2207-2213, 1994.
137. Huang, D.-B., Chang, C.-H., Ainsworth, C., Brünger, A.T., Eulitz, M., Solomon, A., Stevens, F.J., and Schiffer, M. Comparison of crystal structures of two homologous proteins: Structural origin of altered domain interactions in immunoglobulin light-chain dimers. Biochemistry.
33 :14848-
14857, 1994.
138. Ch'ang, L-Y., Schell, M., Ringelberg, C., Weiss, D.T., and Solomon, A. Molecular characterization of a human V 
VIII
germline gene. Mol. Immunol.
32 :49-55, 1995.
139. Eulitz, M., Zirkel, C., Ch'ang, L-Y., Schell, M., Weiss, D.T., and Solomon, A. Distinctive serological, chemical, and molecular properties of human

IV light chains. J. Immunol.
154 :3256-
3265, 1995.
140. Stevens, P.W., Raffen, R., Hanson, D.K., Deng, Y-L., Berrios-Hammond, M., Westholm, F.A.,
Murphy, C., Eulitz, M., Wetzel, R., Solomon, A., Schiffer, M., and Stevens, F.J. Recombinant immunoglobulin variable domains generated from synthetic genes provide a system for in vitro characterization of light-chain amyloid proteins. Protein Sci. 4 :421-432, 1995.
141. Solomon, A. and Weiss, D.T. Structural and functional properties of human

-light-chain variable-region subgroups. Clin. Diagn. Lab. Immunol.
2 :387-394, 1995.
142. Paul, S., Li, L., Kalaga, R., Wilkins-Stevens, P., Stevens, F.J., and Solomon, A. Natural catalytic antibodies: Peptide hydrolyzing activities of Bence Jones proteins and V
L
fragment. J. Biol.
Chem.
270 :15257-15261, 1995.
143. Stevens, F.J., Myatt, E.A., Chang, C-H., Westholm, F.A., Eulitz, M., Weiss, D.T., Murphy, C.,
Solomon, A., and Schiffer, M. A molecular model for self-assembly of amyloid fibrils:
Immunoglobulin light chains. Biochemistry.
34 :10697-10702, 1995.
144. Williams, R.C.,Jr., Malone, C.C., Silvestris, F., and Solomon, A. Molecular localization of human
IgG anti-F(ab')
2
reactivity with variable- and constant-region

light-chain epitopes. J. Clin.
Immunol.
15 :349-362, 1995.
30

145. Kindy, M.S., deBeer, F.C., Markesbery, W.R., Pras, M., Aksentijevich, I., Kastner, D., Kyle, R.,
Solomon, A., and Woo, P. Apolipoprotein E genotypes in AA and AL amyloidoses. Amyloid. J.
Exp. Clin. Invest. 2 :159-162, 1995.
146. Solomon, A. and Weiss, D.T. Protein and host factors implicated in the pathogenesis of lightchain amyloidosis. Amyloid. J. Exp. Clin. Invest. 2 :269-279, 1995.
147. Williams, R.C., Jr., Malone, C.C., Roemer, J.H., Silvestris, F., and Solomon, A. IgG anti-F(ab')
2 antibodies from SLE patients react with immunodominant residues in

CDRs, but show reduced
C

region reactivity. Clin. Immunol. Immunopathol.
77 :366-373, 1995.
148. Niewold, T.A., Murphy, C.L., Gruys, E., Weiss, D.T., and Solomon, A. Equine light-chainassociated amyloidosis (AL amyloidosis). Amyloid. J. Exp. Clin. Invest.
3 :183-186, 1996.
149. Niewold, T.A., Murphy, C.L., Weiss, D.T., and Solomon, A. Characterization of a light-chain product of the human JC

7-gene complex. J. Immunol.
157 :4474-4477, 1996.
150. Huang, D.-B., Ainsworth, C., Solomon, A., and Schiffer, M. Pitfalls of molecular replacement:
The structure determination of an immunoglobulin light-chain dimer. Acta Crystallogr.
D52 :1058-1066, 1996.
151. Roben, P., Barbas, S.M., Sandoval, L., Lecerf, J-M., Stollar, B.D., Solomon, A., and Silverman,
G. J. Repertoire cloning of lupus anti-DNA autoantibodies. J. Clin. Invest.
98 :2827-2837, 1996.
152. Blomberg, B.B. and Solomon, A. The murine and human lambda light chain immunoglobulin loci: Organization and expression. In Handbook of Experimental Immunology. Weir, Ed.,
Volume I, Section 1 (Riblet, R., Ed.), Chapter 10. Blackwell Science Publishers, Cambridge, MA,
1996.
153. Dhodapkar, M.V., Merlini, G., and Solomon, A. Biology and therapy of immunoglobulin deposition diseases. Hematol. Oncol. Clin. North Am.
11 :89-110, 1997.
154. Solomon, A., Weiss, D.T., Schell, M., Ringelberg, C., Ch'ang, L-Y., and Klebig, M.L.
Identification and characterization of a human V  5 (T1) germline gene that encodes structurally unique

light chains. Mol. Immunol.
34 :463-470, 1997.
155. Huang, D.-B., Chang, C-H., Ainsworth, C., Johnson, G., Eulitz, M., Solomon, A., Stevens, F.J., and Schiffer, M. Variable domain structure of the nonpathological human

IV light chain Len:
High homology to the murine light chain McPC603. Mol. Immunol.
34 :1291-1301, 1997.
156. Abe, M., Goto, T., Kosaka, M., Wolfenbarger, D., Weiss, D.T., and Solomon, A. Differences in kappa to lambda (

) ratios of serum and urinary free light chains. Clin. Exp. Immunol.
111 :
457-462, 1998.
157. Solomon, A., Weiss, D.T., Murphy, C.L., Hrncic, R., and Schell, M. Light chain-associated (AL) amyloid deposits composed of a novel

constant domain. Proc. Natl. Acad. Sci USA. 95 : 9547-
31

9551, 1998.
158. Sun, Y., Park, M.K., Kim, J., Diamond, B., Solomon, A., and Nahm, M. Repertoire of humanantibodies against the polysaccharide capsule of Streptococcus penumoniae serotype 6B.
Infect. Immun. 67 : 1172-79, 1999.
159. Stevens, F., Weiss, D.T., and Solomon, A. Structural bases of light chain-related pathology. In
The Antibodies. Zanetti, M., and Capra, J.D., Eds. Volume 5, pp. 175-208. Harwood
Academic Publishers, Langehorne, PA, 1999.
160. Solomon, A., Weiss, D.T., Schell, M., Hrncic, R., Murphy, C.L., Wall, J., McGavin, M.D., Pan,
H.J., Kalbalka, G.W., and Paulus, M.J. Transgenic mouse model of AA amyloidosis. Am. J.
Pathol. 154 : 1267-1272, 1999.
161. Kaplan, B., Hrncic, R., Murphy, C.L., Gallo, G., Weiss, D.T., and Solomon, A. Microextraction and purification techniques applicable to the chemical characterization of amyloid proteins in minute amounts of tissue. Methods Enzymol . 309 :67-81, 1999.
162.
Wall, J., Murphy, C.L. and Solomon, A. In vitro immunoglobulin light chain fibrillogenesis.
Methods Enzymol . 309 :204-217, 1999.
163.
Wall, J. and Solomon, A. Flow cytometric characterization of amyloid fibrils. Methods Enzymol .
309 : 460-466, 1999.
164.
Jokiranta, T.S., Solomon, A., Pangburn, M.K., Zipfel, P.F., and Meri, Seppo. Nephritogenic
 light- chain dimer: a unique human miniautoantibody against complement factor H. J. Immunol .
163 : 4590- 4596, 1999.
165.
Wall, J., Schell, M., Murphy, C.L., Hrncic, R., Stevens, F.J., and Schiffer, M.: Thermodynamic instability of human

6 light chains: Correlation with fibrillogenicity. Biochemistry. 38 : 14101-
14108, 1999.
166.
Pokkuluri, P.R., Solomon, A., Weiss, D.T., Stevens, F.J., and Schiffer, M. Tertiary structure of human

6
 light chains. Amyloid. J. Exp. Clin. Invest. 6 , 165-171, 1999.
167. Kim, Y., Wall, J.S., Meyer, J., Murphy, C., Randolph, T.W., Manning, M.C., Solomon, A., and
Carpenter, J.F. Thermodynamic modulation of light chain amyloid fibril formation. J. Biol.
Chem.
275 , 1570-1574 , 2000.
168. Hrncic, R., Wall, J.S., Wolfenbarger, D.A., Murphy, C.L., Schell, M., Weiss, D.T., and Solomon,
A. Antibody-mediated resolution of light chain-associated (AL) amyloid deposits. Am. J. Pathol.
157 , 1239-1246, 2000.
169. Murphy, C.L., Eulitz, M., Hrncic, R., Sletten, K., Westermark, P., Williams, T., Macy, S.D.,
Wooliver, C., Wall, J., Weiss, D.T., and Solomon, A. Chemical typing of amyloid protein contained in formalin-fixed paraffin-embedded biopsy specimens. Am. J. Clin. Pathol . 116 ,
135-142, 2001.
32

170. Kaplan, B., Murphy, C.L., Ratner, V., Pras, M. Weiss, D.T., and Solomon, A. Micro-method to isolate and purify amyloid proteins for chemical characterization. Amyloid. J. Protein Folding
Disord.
8 , 22-29, 2001.
171. Kim, Y-S, Cape, S.P., Chi, E., Raffen, R., Wilkins-Stevens, P., Stevens, F.J., Manning, M.C.,
Randolph, T.W., Solomon, A., and Carpenter, J.F. Counteracting effects of renal solutes on amyloid fibril formation by immunoglobulin light chains. J. Biol. Chem . 276 , 1626-1633, 2001.
172.
Bergström, J., Murphy, C., Eulitz, M., Weiss, D.T., Westermark, G.T., Solomon, A., and
Westermark, P. Codeposition of Apolipoprotein A-IV and Transthyretin in Senile Systemic
(ATTR) Amyloidosis. Biochem. Biophys. Res. Commun . 285 , 903-908, 2001.
173.
Solomon, A., Weiss, D.T., and Wall, J. Primary (AL) Amyloidosis: Recent Discoveries Regarding
Pathogenesis, Diagnosis, and Treatment. In Amyloid and Amyloidosis, The Proceedings of the
IXth International Symposium on Amyloidosis. Bély, M., Apáthy, Á. Eds. Hungary, 2001, pp.
256-262.
174.
Coriu, D., Murphy, C.L., Macy, S., Weaver, K., Schell, M., and Solomon,A. Transthyretin
Amyloidosis (ATTR) Thr60ala (Appalachian) Variant: A Family Study. In Amyloid and
Amyloidosis, The Proceedings of the IXth International Symposium on Amyloidosis. Bély, M.,
Apáthy, Á. Eds. Hungary, 2001, pp. 349-351.
175.
Hrncic, R., Wolfenbarger, D.A., Macy, S., Wooliver, C., Wall, J., Weiss, D.T., and Solomon, A.
Vaccine-Based Therapy for Primary (AL) Amyloidosis. In Amyloid and Amyloidosis, The
Proceedings of the IXth International Symposium on Amyloidosis. Bély, M., Apáthy, Á. Eds.
Hungary, 2001, pp. 234-235.
176.
Murphy, C.L., Williams, T.K., Weiss, D.T., and Solomon, A. A Novel Amyloid Protein in
Calcifying Epithelial Odontogenic (Pindborg) Tumor. In Amyloid and Amyloidosis, The
Proceedings of the IXth International Symposium on Amyloidosis. Bély, M., Apáthy, Á. Eds.
Hungary, 2001, pp. 422-423.
177.
Schell, M., Wall, J., Macy, S., Wooliver, C., Wolfenbarger, D.A., Weiss, D.T., and Solomon, A.
Prevention of AA Amyloidosis by Active Immunotherapy. In Amyloid and Amyloidosis, The
Proceedings of the IXth International Symposium on Amyloidosis. Bély, M., Apáthy, Á. Eds.
Hungary, 2001, pp. 146-148.
178.
Wall, J., Schell, M., Hrncic, R., Macy, S., Wooliver, C., Wolfenbarger, C., Murphy, C., Donnell,
R., Weiss, D.T. and Solomon, A. Treatment of Amyloidosis Using an Anti-Fibril Monoclonal
Antibody: Pre-Clinical Efficacy in a Murine Model of AA-Amyloidosis. In Amyloid and
Amyloidosis, The Proceedings of the IXth International Symposium on Amyloidosis. Bély, M.,
Apáthy, Á. Eds. Hungary, 2001, pp.158-160.
179.
Bergström, J., Murphy, C.L., Eulitz, M.,.Weiss, D.T., Westermark, G.T., Solomon, A., and
Westermark, P. Apolipoprotein A-IV Co-Deposited with Transthyretin in Senile Systemic
Amyloidosis. In Amyloid and Amyloidosis, The Proceedings of the IXth International Symposium
33

on Amyloidosis. Bély, M., Apáthy, Á. Eds. Hungary, 2001, pp. 86-87.
180.
Müller, D., Röcken, C., and Solomon, A. Localization of Coagulation Factor X in AL and AA
Amyloid. In Amyloid and Amyloidosis, The Proceedings of the IXth International Symposium on
Amyloidosis. Bély, M., Apáthy, Á. Eds. Hungary, 2001, pp. 279-280.
181.
Tang, L.X., Wolfenbarger, D., Williams, T., Weiss, D.T., and Solomon, A. Clinical Importance of
Serum and Urine Free Kappa and Lambda Light Chain Concentrations in Primary (AL)
Amyloidosis.
In Amyloid and Amyloidosis, The Proceedings of the IXth International Symposium on Amyloidosis. Bély, M., Apáthy, Á. Eds. Hungary, 2001, pp. 284-286.
182. Lundmark, K., Westermark, G., Nyström, S., Murphy, C., Solomon, A., and Westermark, P.
Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc. Natl. Acad. Sci. USA.
99, 6979-6984, 2002.
183.
Solomon, A. and Westermark, P. Hereditary amyloidosis, Letter to the Editor. N. Engl. J. Med .
347 , 1206, 2002.
184. Solomon, A., Weiss, D.T., and Herrera, G.A. Light chain deposition disease: clinicopathologic and biologic features. In Myeloma. Mehta, J., Singhal, S. Eds. Martin Dunitz Ltd., London,
England. 2002 pp. 507-518.
185. Ménsua C., Carrasco L., Bautista M.J., Biescas E., Fernández A., Murphy C.L., Weiss D.T.,
Solomon A., and Luján L. Pathology of AA amyloidosis in domestic sheep and goats. Vet.
Pathol.
40 ,71-80, 2003.
186. Khurana, R., Souillac, P.O., Coats, A.C., Minert, L., Ionescu-Zanetti, C., Carter, S.A., Solomon,
A., and Fink, A.L. A model for amyloid fibril formation in immunoglobulin light chains based on comparison of amyloidogenic and benign proteins and specific antibody binding. Amyloid . J.
Protein Folding Disord . 10 ,97-109, 2003.
187. Solomon, A., Murphy, C.L., Hrncic, R., Weiss, D.T., Tang, L.X., Donnell, R.L., Sletten, K.,
Westermark, G., and Westermark, P. Calcifying epithelial odontogenic (Pindborg) tumorassociated amyloid consists of a novel human protein. J.
Lab. Clin. Med . 142 ,348-355, 2003.
188. Westermark, P., Bergström, J., Solomon, A., Murphy, C., and Sletten, K. Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations. Amyloid . J. Protein
Folding Disord .
10 ,48-54, 2003.
189. Solomon, A., Weiss, D.T., and Wall, J.S. Therapeutic potential of chimeric amyloid-reactive monoclonal antibody 11-1F4. Clin. Cancer Res. 9 ,3831s-3838s, 2003.
190. Solomon, A., Weiss, D.T., and Wall, J.S. Immunotherapy in systemic primary (AL) amyloidosis using amyloid-reactive monoclonal antibodies. Cancer Biother. Radiopharm. 18 ,853-859, 2003.
191.
Coriu, D., Dispenzieri, A., Stevens, F.J., Murphy, C.L., Wang, S., Weiss, D.T., and Solomon A.
Hepatic amyloidosis resulting from deposition of the apolipoprotein A-I variant Leu75Pro.
34

Amyloid. J. Protein Folding Dis.10 ,215-223, 2003.
192. Wall, J.S., Gupta, V., Wilkerson, M., Schell, M., Loris, R., Adams, P., Solomon, A., Stevens, F., and Dealwis, C. Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four V  6 proteins. J. Mol . Regcognit.
17 ,323-331, 2004.
193.
Bergström, J., Murphy, C.L., Weiss, D.T., Solomon, A., Sletten, K., Hellman, U., and
Westermark, P. Two different types of amyloid deposits – apolipoprotein A-IV and transthyretin
– in a patient with systemic amyloidosis. Lab. Invest. 84, 981-988 , 2004 .
194. Coriu, D., Weaver, K., Schell, M., Eulitz, M., Murphy, C.L., Weiss, D.T., and Solomon, A. A molecular basis for nonsecretory myeloma. Blood . 104 :829-831, 2004.
195. Murphy, C.L., Wang, S., Weaver, K., Gertz, M., Weiss, D.T., and Solomon, A. Renal apolipoprotein A-I amyloidosis associated with a novel mutant Leu64Pro. Am. J. Kid. Dis .
44 :1103-1109, 2004.
196. Solomon, A., Weiss, D.T., and Herrera, G.A. Renal diseases associated with multiple myeloma and related plasma cell dyscrasias. In Biology and Management of Multiple Myeloma. Berenson,
J.R. Ed. Humana Press, New Jersey, 2004; pp. 281-302.
197. Ludlage, E., Murphy, C.L., Davern, S.M., Solomon, A., Weiss, D.T., Glenn-Smith, D., Dworkin,
S., and Mansfield, K.G. Systemic AA amyloidosis in the common marmoset. Vet. Path . 42 :117-
124, 2005.
198. Murphy, C.L., Wang, S., Weaver, K., Gertz, M.A., Weiss, D.T., and Solomon, A. Renal apolipoprotein A-I amyloidosis (AAPO-A-I) associated with a novel mutant Leu64Pro. Xth
International Symposium on Amyloidosis . Tours, France, CRC Press, pp 363-365, 2005.
199. Solomon, A., Weiss, D.T., and Wall, J.S. Immunotherapy of AL amyloidosis.
Xth International
Symposium on Amyloidosis . Tours, France, CRC Press, pp 479-481, 2005.
200. Murphy, C.L., Wang, S., Kestler, D.P., Macy, S.D., Williams, T.K., Carlson, E.R., Weiss, D.T., and Solomon, A. Pindborg tumor-associated amyloid proteins. Xth International Symposium on
Amyloidosis . Tours, France, CRC Press, pp 468-470, 2005.
201. Wall, J.S., Kennel, S.J., Paulus, M.J., Gleason, S., Gregory, J., Wolfenbarger, D.A., Weiss, D.T., and Solomon, A. Radioimaging of primary (AL) amyloidosis with an amyloid-reactive monoclonal antibody. Xth International Symposium on Amyloidosis . Tours, France, CRC Press, pp 37-39, 2005.
202. Murphy, C.L., Crombie, B., Williams, T.K., Macy, S.D., Weiss, D.T., Solomon, A., and Nout,
Y.S. Systemic equine AL amyloidosis. Xth International Symposium on Amyloidosis . Tours,
France, CRC Press, pp 35-36, 2005.
35

203. Wall, J.S., Murphy, C.L., Tomazewski, A., Crombie, B., and Solomon, A. Structural localization of light chain amyloidogenicity.
Xth International Symposium on Amyloidosis . Tours, France,
CRC Press, pp 52-54, 2005.
204. Murphy, C.L., Wang, S., Crombie, B., Macy, S.D., Williams, T.K., Weiss, D.T., and Solomon, A.
Medullary thyroid carcinoma-associated amyloid is comprised of calcitonin gene-related peptide
II.
Xth International Symposium on Amyloidosis . Tours, France, CRC Press, pp 443-445, 2005.
205. Linke, R.P., Joswig, R., Murphy, C.L., Wang, S., Zhou, H., Gross, U., Röcken, C., Nathrath
W.B.J., Westermark, P., Weiss, D., and Solomon, A. Semenogelin I is the amyloidogenic protein in senile seminal vesicles. Xth International Symposium on Amyloidosis . Tours, France, CRC
Press, pp 471-473, 2005.
206. Gertz, M.A., Comenzo, R., Falk, R.H., Fermanci, J.P., Hazenberg, B.P., Hawkins, P.N., Merlini,
G., Moreau, P., Ronco, P., Sanchorawala, V., Sezer, O., Solomon, A., and Grateau, G. Definition of organ involvement and treatment response in primary systemic amyloidosis (AL): a consensus opinion from the 10 th
international symposium on amyloid and amyloidosis. Xth International
Symposium on Amyloidosis . Tours, France, CRC Press, pp 151-153, 2005.
207. O’Nuallain B., Murphy, C., Wolfenbarger, D., Kennel, S., Solomon, A., and Wall, J. The amyloidreactive monoclonal antibody 11-1F4 binds a cryptic epitope of fibrils and partially denatured immunoglobulin light chains and inhibits fibrillogenesis. Xth International Symposium on
Amyloidosis . Tours, France, CRC Press, pp 482-484, 2005.
208. Ludlage, E., Murphy, C.L., Solomon, A., Weiss, D.T., Glenn-Smith, D., Dworkin, S., and
Mansfield, K.G. Systemic AA amyloidosis in the common marmoset. Xth International
Symposium on Amyloidosis . Tours, France, CRC Press, pp 247-249, 2005.
209. Kraneveld, A.D., Kool, M., van Houwelingen, A.H., Roholl, P., Solomon, A., Postma, D.S.,
Nijkamp, F.P., and Redegeld, F.A. Elicitation of “allergic” asthma by immunoglobulin free light chains. Proc. Natl. Acad. Sci. USA . 102 ,1578-1583, 2005.
210. Bergström, J., Gustavsson, A., Hellman, U. Sletten, K., Murphy C.L., Weiss, D.T., Solomon, A.
Olofsson, B.O., Westermark, P. Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology. J. Pathol . 206 ,224-232, 2005.
211. Gertz, M.A., Comenzo, R., Falk, R.H., Fermand, J.P., Hazenberg, B.P., Hawkins, P.N., Merlini,
G., Moreau, P., Ronco, P., Sanchorawala, V., Sezer, O., Solomon, A., and Grateau, G. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10 th international symposium on amyloid and amyloidosis. Am. J.
Hem . 79 ,319-328, 2005.
212. Wall, J.S., Kennel, S.J., Paulus, M.J., Gleason, S., Gregor, J., Baba, J., Schell, M., Rickey, T.,
36

O’Nuallain, B., Donnell, R., Hawkins, P.N., Weiss, D.T., and Solomon, A. Quantitative highresolution microradiographic imaging of amyloid deposits in a novel murine model of AAamyloidosis. Amyloid . 12 ,149-156, 2005.
213. Niewold, T.A., Murphy, C.L., Toussaint, M.J.M., Solomon, A., and Gruys, E. Chemical typing of procine systemic amyloid as AA-amyloid. Amyloid . 12 ,164-166, 2005.
214. Gregor, J., Gleason, S., Kennel, S., Paulus, M., Solomon, A., Hawkins, P., and Wall, J. A micro
SPECT/CT system for imaging of AA-amyloidosis in mice. In Small-Animal SPECT Imaging.
Kupinski, M. and Barrett, H. Eds. Plenum USA, 2005, pp. 209-213.
215. Linke, R.P., Joswig, R., Murphy, C.L., Wang, S., Zhou, H., Gross, U., Rocken, C., Westermark,
P., Weiss, D.T., and Solomon, A. Senile seminal vesicle amyloid is derived from semenogelin I. J .
Lab. Clin. Med . 145 ,187-193, 2005.
216. O’Nuallain, B., Hrncic, R., Wall, J.S., Weiss, D.T., and Solomon, A. Diagnostic and therapeutic potential of amyloid-reactive IgG antibodies contained in human sera. J. Immunol . 176 ,7071-
7078, 2006.
217. Murphy, C.L., Wang, S., Williams, T., Weiss, D.T., and Solomon, A. Characterization of systemic amyloid deposits by mass spectrometry. Methods Enzymol . 412 ,48-62, 2006.
218. Wall, J.S., Paulus, M.J., Gleason, S., Gregor, J., Solomon, A., and Kennel, S.J. Micro-imaging of amyloid in mice. Methods Enzymol . 412 ,161-184, 2006.
219. Solomon, A., Murphy, C.L., and Westermark, P. Misclassification of amyloidosis is unwarranted.
Blood . 108 ,776, 2006.
220. Shafeeq, S., Ladha, P., Dyck, J.B., Spinner, R.J., Perez, D.G., Zeldenrust, S.R., Amrami, K.K.,
Solomon, A., and Klein, C.J. Isolated amyloidosis presenting with lumbosacral radiculoplexopathy: description of two cases and pathogenic review. J.P.N.S
. 11 ,346-352, 2006.
221. Solomon, A., Murphy, C.L., Kestler, D., Coriu, D., Weiss, D.T., Makovitzky, J., and Westermark,
P. Amyloid contained in the knee joint meniscus is formed from apolipoprotein A-I. Arthritis
Rheum . 54 ,3545-3550, 2006.
222. Wall, J.S., Kennel, S.J., Paulus, M., Gregor, J., Richey, T., Avenell, J., Yap, J., Townsend, D.,
Weiss, D.T., and Solomon, A. Radioimaging of light chain amyloid with a fibril-reactive monoclonal antibody. J. Nucl. Med . 47 ,2016-2024, 2006.
223. O’Nuallain, B., Allen, A., Kennel, S.J., Weiss, D.T., Solomon, A., and Wall, J.S. Localization of a conformational epitope common to non-native and fibrillar immunoglobulin light chains.
Biochemistry . 46 ,1240-1247, 2007.
224. Solomon, A., Richey, T., Murphy, C.L., Weiss, D.T., Wall, J.S., Westermark , G.T., and
Westermark , P. Amyloidogenic potential of foie gras. Proc. Natl. Acad. Sci.
104 ,10998-11001,
2007.
37

225. Donnell, R., Murphy, C.L., Eulitz, M. Williams, T.K., Macy, S.D., Weiss, D.T., and Solomon, A.
Odontogenic feline and canine tumor-associated amyloid is formed from ameloblastin. XIth
International Symposium on Amyloidosis . Woods Hole, MA, CRC Press, pp. 56-58, 2007.
226. Foster, J.S., Kestler, D.P., Murphy, C.L., Kennel, S.J., Wall, J.S., Weiss, D.T., and Solomon, A.
Amyloidogenic region of odontogenic ameloblast associated protein (ODAM). XIth International
Symposium on Amyloidosis . Woods Hole, MA, CRC Press, pp. 59-61, 2007.
227. Kennel, S.J., Richey, T., Avenell, J.S., Hawkins, P.N., Solomon, A., and Wall, J.S. Advances in non-invasive imaging of AA amyloid in mice. XIth International Symposium on Amyloidosis .
Woods Hole, MA, CRC Press, pp. 65-67, 2007.
228. Kestler, D.P., Hudson, J., Macy, S.D., Murphy, C.L., Foster, J.S., Weiss, D.T., and Solomon, A.
Detection and identification of amyloid deposition associated with human unerupted tooth follicles. XIth International Symposium on Amyloidosis . Woods Hole, MA, CRC Press, pp. 68-69,
2007.
229. Richey, T., Murphy, C.L., Wall, J.S., Westermark, G.T., Westermark, P., Weiss, D.T., and
Solomon, S. Foie gras is a dietary source of AEF. XIth International Symposium on Amyloidosis .
Woods Hole, MA, CRC Press, pp. 90-92, 2007.
230. Wang, S., Murphy, C.L., Kestler, D., Macy S.D., Williams, T.K., Weiss, D.T., and Solomon, A.
SAA
4
-related AA amyloidosis. XIth International Symposium on Amyloidosis . Woods Hole, MA,
CRC Press, pp. 105-107, 2007.
231. Landau, H.J., Comenzo, R.L., Zhou, P., Clark, B., Teruya-Feldstein, J., Wang, S., Murphy, C.L., and Solomon, A. AL amyloidosis in a patient with a T60A TTR mutation. XIth International
Symposium on Amyloidosis . Woods Hole, MA, CRC Press, pp. 160-162, 2007.
232. Macy, S.D., Williams, T.K., Wooliver, C., Murphy, C.L., Wang, S., Kestler, D., Westermark, P.,
Weiss, D.T., and Solomon, A. Apolipoprotein A-I (apo A-I) nature of knee joint meniscusassociated amyloid. XIth International Symposium on Amyloidosis . Woods Hole, MA, CRC Press, pp. 166-168, 2007.
233. Wooliver, C., Coriu, D., Murphy, C.L., Kestler, D.P., Wang, S., Weiss, D.T., and Solomon, A.
Familial amyloidosis associated with a novel mutation (D68G) in the lysozyme gene. XIth
International Symposium on Amyloidosis . Woods Hole, MA, CRC Press, pp. 208-210, 2007.
38

234. Acero, L., Solomon, A., Wall, J.S., and O’Nuallain, B. Identification of novel inhibitors of light chain fibrillogenesis. XIth International Symposium on Amyloidosis . Woods Hole, MA, CRC
Press, pp. 222-224, 2007.
235. Allen, A., Kennel, S.J., Solomon, A., Wall, J.S., and O’Nuallain, B. Peptide phage display and epitope mapping of a fibril-related conformational epitope recognized by the 11-1F4 monoclonal antibody. XIth International Symposium on Amyloidosis . Woods Hole, MA, CRC Press, pp. 225-
227, 2007.
236. Eulitz, M., Murphy, C.L., Weiss, D.T., and Solomon, A. Role of light chain deamidation in the pathogenesis of AL amyloidosis. XIth International Symposium on Amyloidosis . Woods Hole,
MA, CRC Press, pp. 246-248, 2007.
237. O’Nuallain, B., Allen, A., Richey, T., Wall, J.S., Weiss, D.T., and Solomon, A. Therapeutic potential of naturally occurring fibril-reactive human antibodies for AL amyloidosis. XIth
International Symposium on Amyloidosis . Woods Hole, MA, CRC Press, pp. 278-280, 2007.
238. Phipps, J.E., Foster, J.S., Kestler, D.P., Solomon, A., and Wall, J.S. In vitro silencing of amyloidogenic

6 light chain production. XIth International Symposium on Amyloidosis . Woods
Hole, MA, CRC Press, pp. 286-288, 2007.
239. Sletten, K., Wang, S., Murphy, C.L., Stevens, F.J., Weiss, D.T., and Solomon, A. Glycosylated amyloid and non-amyloid associated lambda light chains. XIth International Symposium on
Amyloidosis . Woods Hole, MA, CRC Press, pp. 301-303, 2007.
240. Solomon, A., Weiss, D.T., Macy, S.D., Wooliver, C., and Westermark, P. Extramedullary production of AL amyloid precursor protein. XIth International Symposium on Amyloidosis .
Woods Hole, MA, CRC Press, pp. 304-306, 2007.
241. Wall, J.S., Kennel, S.J., Richey, T., Avenell, J.S. and Solomon, A. Imaging human AL amyloid in mice using the fibril-reactive monoclonal antibody 11-1F4. XIth International Symposium on
Amyloidosis . Woods Hole, MA, CRC Press, pp. 315-317, 2007.
242. Weiss, D.T., Wooliver, C., and Solomon, A. Histochemical-based staging system for AL amyloidosis. XIth International Symposium on Amyloidosis . Woods Hole, MA, CRC Press, pp.
327-329, 2007.
243. Williams, T.K., Macy, S.D., Wooliver, C., Murphy, C.L., Gorevic, P., Westermark, P., Weiss,
D.T., and Solomon, A. Localized AL amyloidosis: a distinctive clinicopathologic disorder. XIth
39

International Symposium on Amyloidosis . Woods Hole, MA, CRC Press, pp. 330-332, 2007.
244. Murphy, C.L., Wang, S., Williams, T.K., Weiss, D.T., and Solomon, A. Definitive identification of amyloid deposits by mass spectrometry. XIth International Symposium on Amyloidosis . Woods
Hole, MA, CRC Press, pp. 363-364, 2007.
245. O’Nuallain, B., Allen, A., Ataman, D., Weiss, D.T., Solomon, A., and Wall, J. Phage display and peptide mapping of an immunoglobulin light chain fibril-related conformational epitope.
Biochemistry , 46 :13049-13058, 2007.
246. Solomon, A., Murphy, C.L., and Westermark, P. Unreliability of immunohistochemistry for typing amyloid deposits. Arch. Pathol. Lab. Med.
, 132 :14, 2008.
247. Del Pozo Yauner, L., Ortiz, E., Sánchez, R., Sánchez-López, R., Gűereca, L., Murphy, C.L.,
Allen, A., Wall, J.S., Fernández-Velasco, D.A., Solomon, A., and Bercerril, B. Influence of the germline sequence on the thermodynamic stability and fibrillogenicity of human lambda 6 light chains. Proteins . 72 :684-692, 2008.
248. Murphy, C.L., Kestler, D.P., Foster, J.S., Wang, S., Macy, S.D., Kennel, S.J., Carlson, E.R.,
Hudson, J., Weiss, D.T., and Solomon, A. Odontogenic ameloblast-associated protein nature of the amyloid found in calcifying epithelial odontogenic tumors and unerupted tooth follicles.
Amyloid . 15 :89-95, 2008.
249. Kestler, D.P., Foster, J.S., Macy, S.D., Murphy, C.L., Weiss, D.T., and Solomon, A. Expression of odontogenic ameloblast-associated protein (ODAM) in dental and other epithelial neoplasms. Mol.
Med . 14 :318-326, 2008.
250. Davern, S. Tang, L.X., Williams, T.K., Macy, S.D., Wall, J.S., Weiss, D.T., and Solomon, A.
Immunodiagnostic capabilities of anti-free immunoglobulin light chain monoclonal antibodies.
Am . J. Clin. Pathol . 130:702-711, 2008.
251. O’Nuallain, B., Acero, L., Williams, A.D., McWilliams Koeppen, H.P., Weber, A., Schawarz,
H.P., Wall, J.S., Weiss, D.T., and Solomon, A. Human plasma contains cross-reactive A
 conformer-specific IgG antibodies. Biochemistry . 47:12254-12256, 2008.
252. Wall, J.S., Richey, T., Allen, A., Donnell, R., Kennel, S.J., and Solomon, A. Quantitative tomography of early-onset spontaneous AA amyloidosis in interleukin 6 transgenic mice. Comp.
Med . 58:542-550, 2008.
Abstracts
1. Fahey, J.L., Solomon, A. and Malmgren, R. Immunochemical basis for the recognition of
40

macroglobulinemia and multiple myeloma. Proc. Am. Assoc. Cancer Res.
, 1961.
2. Solomon, A., Fahey, J.L. and Waldmann, T. Metabolism of normal 6.6S

-globulin in macroglobulinemia and multiple myeloma. Clin. Res.
10 :207, 1962.
3. Solomon, A., Fahey, J.L. and Malmgren, R.A. Immunohistological localization of macroglobulins and
 and

2A
-myeloma proteins and Bence Jones proteins. Proc. Am. Assoc. Cancer Res.
, 1962.
4. Solomon, A. and Fahey, J.L. Plasmapheresis therapy in macroglobulinemia. Ann. Intern. Med.,
56 :690-691, 1962.
5.
6.
7.
Solomon, A. Metabolism of group I and group II 7S

-globulin.
Solomon, A. and Tomasi, T.B., Jr. Metabolism of IgA (

2A
Clin. Res.
) globulin.
12 :238, 1964.
Clin. Res.
12 :452, 1964.
Solomon, A., Litwin, S.D. and Kunkel, H.G. Marked antigenic and other differences among
Bence Jones proteins containing similar genetic factors. Fed. Proc.
24 :201, 1965.
8. Solomon, A. and Kunkel, H.G. A "monoclonal" type low-molecular weight protein related to

M macroglobulins. Blood.
26 :880-881, 1965.
9. Caggiano, V., Cuttner, J. and Solomon, A. Effect of chemotherapy on the immunoglobulin levels in multple myeloma. Proc. Am. Assoc. Cancer Res.7 :11, 1966.
10. Solomon, A. Molecular polymorphism of

M-globulin. Fed. Proc.
26 :529, 1967.
11. Solomon, A. Molecular heterogeneity among immunoglobulins. J. Lab. Clin. Med.
70 :876-877,
1967.
12. Solomon, A. and McLaughlin, C.L. Molecular polymorphism of

M-globulin: In vitro and in vivo studies. Blood.
30 :871-872, 1967.
13. Solomon, A. and McLaughlin, C.L. Subunits of Bence Jones proteins and immunoglobulin light chains. Clin. Res.
16 :324, 1968.
14. Solomon, A. and McLaughlin, C.L. Production of Bence Jones protein subunits. Proc. of the XII
Congress of the International Society of Hematology , p. 140, 1968.
15. Solomon, A. and McLaughlin, C.L. Subgroups of

-type Bence Jones proteins. Fed. Proc.
28 :495, 1969.
16. Solomon, A. and McLaughlin, C.L. Subclasses of kappa-light chains: Immunochemical and structural correlation. J. Lab. Clin. Med.
74 :1013, 1969.
17. Solomon, A. and McLaughlin, C.L. Immunochemical differentiation of Bence Jones proteins within each major

-chain class. Fed. Proc.
29 :258, 1970.
41

18. Solomon, A. and McLaughlin, C.L. Localization of antigenic sites responsible for

light chain heterogeneity. Fed. Proc.
30 :594, 1971.
19. Solomon, A. and McLaughlin, C.L. Localization of antigenic sites responsible for immunochemical heterogeneity of kappa light chains. Fed. Proc.
31 :772, 1972.
20. Solomon, A. and McLaughlin, C.L. Detection of a hidden antigenic site localized to the constant region of kappa light chains. Fed. Proc.
32 :1004, 1973.
21. Longworth, J.W., McLaughlin, C.L. and Solomon, A. Fluorescence spectra and lifetimes of
Bence Jones proteins and light chains of immunoglobulins. Fed. Proc.
32 :458, 1973.
22. Longworth, J.W., McLaughlin, C.L. and Solomon, A. An atypical tryptophan phosphorescence from human leukemia lysozyme. Proc. of the IX International Congress of Biochemistry , pp. 104,
1973.
23. McLaughlin, C.L., Solomon, A. and Longworth, J.W. Luminescence of constant and variant halves of Bence Jones proteins and light chains of immunoglobulins. Proc. of the IX International
Congress of Biochemistry , pp. 313, 1973.
24. Solomon, A., McLaughlin, C.L. and Longworth, J.W. Phosphorescence spectra and lifetimes of
Bence Jones proteins and light chains of immunoglobulins. Proc. of the IX International
Congress of Biochemistry , pp. 310, 1973.
25. McLaughlin, C.L. and Solomon, A. Immunochemical typing of non-isolated light chains of immunoglobulins. Fed. Proc.
33 :726, 1974.
26. Steinberg, A.G., Milstein, C.P., McLaughlin, C.L. and Solomon, A. Primary structure of an
Inv(1,-2)

light chain. Fed. Proc.
33 :737, 1974.
27. Longworth, J.W., McLaughlin, C.L. and Solomon, A. Atypical phosphorescence spectra and lifetimes of Bence Jones proteins and light chains of immunoglobulins. Fed. Proc. 33 :1384,1974.
28. Solomon, A. and McLaughlin, C.L. Transitory appearance of a new Bence Jones-related protein associated with corticosteroid therapy. J. Clin. Invest.
53 :77a, 1974.
29. Lozzio, C.B., Solomon, A., Lozzio, B.B. and Klepper, M.B. Characterization of a multiple myeloma cell line of human origin. International Research Communication System--Medical
Sciences (suppl) 3 :14, 1975.
30. Solomon, A. and Havemann, K. Effect of neutral proteases derived from human granulocytes on
Benc Jones proteins. Blood. 46 :1019, 1975.
31. Feizi, T., Lecomte, J., Childs, R. and Solomon, A. Unsuspected V

III subgroup in an idiotypic antiserum against a human IgM

cold agglutinin. Fed. Proc.
35 :550, 1976.
32. Tornyos, K., Silberman, H. and Solomon, A. Oral methyl-CCNU and prednisone in previously
42

treated multiple myeloma. Proc. Am. Assoc. Cancer Res. and Am. Society Clin. Oncol.
17 :257,
1976.
33. Solomon, A. Heparin-binding human immunoglobulins (Ig). Clin. Res.
24 :450A, 1976.
34. Solomon, A. Bence Jones proteins and light chain fragments: Biochemical and clinical studies.
Proceedings of the 16th International Congress of Hematology , pp. 79, 1976.
35. Solomon, A. Effect of corticosteroids on synthesis and excretion of Bence Jones proteins. Proc.
Am. Society of Hematol, , pp. 140, 1976.
36. Longworth, J.W., McLaughlin, C.L., and Solomon, A. Luminescence studies of Bence Jones proteins and light chains of immunoglobulins. In Excited States of Biological Molecules. J.B.
Birks, Ed., Wiley, London, 1976, pp. 402-403.
37. Solomon, A. Therapeutic-associated alterations in synthesis and excretion of Bence Jones proteins. Proc. Am. Assoc. Cancer Res. and American Society of Clinical Oncology.
18 :153, 1977.
38. Solomon, A. Recognition of chemotherapeutic-associated alterations of monoclonal and polyclonal immunoglobulins in multiple myeloma and lymphoma. Proc. Am. Assoc. Cancer Res. and American Society of Clinical Oncology.
19 :373, 1978.
39. Levy, D.E. and Solomon, A. Binding of sulfated polysaccharides by human immunoglobulins.
Fed. Proc.
37 :1278, 1978.
40. Stevens, F., Westholm, F., Solomon, A. and Schiffer, M. Heterogeneity of

I
light chains. Fed.
Proc.
38 :940, 1979.
41. Stevens, F.J., Westholm, F., Solomon, A. and Schiffer, M. Computer simulation of small zone gel filtration: Heterologous association of immunoglobulin light chains. Fed. Proc. 39 :2210, 1980.
42. Koopman, W.J., Solomon, A. and Schrohenloher, R.E. IgA rheumatoid factor (RF) in rheumatoid arthritis (RA). Clin. Res.
28 :351A, 1980.
43. Griffin, G.D., Owen, B.A., Atchley, C., Solomon, A., Walsh, P.J. and Novelli, G.D.
Immunoglobulin (IgG) production in a human lymphoblastoid cell line: Alteration by melphalan, a cancer chemotherapy agent. Proc. Am. Assoc. Cancer Res.22 :108, 1981.
44. Griffin, G.D., Owen, B.A., Lynch, A., Atchley, C., Walsh, P.J., Solomon, A. and Novelli, G.D.
Control of synthesis and excretion of immunoglobulin by human lymphoblastoid cell line. Fed.
Proc.
40 :702, 1981.
45. Short, M., Stevens, F.J., Westholm, F., Solomon, A. and Schiffer, M. Crystallographic investigation of a

-Bence-Jones protein Loc. Fed. Proc.
41 :287, 1982.
46. Ledford, D.K., Goni, F., Solomon, A., Franklin, E.C. and Frangione, Blas.

IIIb is the predominant light chain in the human monoclonal IgM autoimmune response. Clin.
43

Res.,30 :473A, 1982.
47. Solomon, A., Frangione, B. and Franklin, E.C. Preferential association of the V 
VI
subgroup of human light chains with amyloidosis AL. Clin. Res.
30 :515A, 1982.
48. Solomon, A. Development of monoclonal immunoglobulins after cytotoxic chemotherapy. 13 th
International Cancer Congress , Seattle, Washington, September 7-15, pp. 218, 1982.
49. Schiffer, M., Chang, C-H., Short, M., Westholm, F. and Solomon, A. Structural studies of

-I-
Bence-Jones protein Loc. Fed. Proc.
42 :2435, 1983.
50. Schrohenloher, R., Koopman, W. and Solomon, A. Activity of rheumatoid factors (RF) of different molecular sizes: Comparison of monomeric and polymeric monoclonal IgA RF from the same patient. Arthritis Rheum.
26 :S50, 1983.
51. Solomon, A. and Machado, E. Nephrotoxicity of human Bence Jones protein. Clin. Res.
33 :354A, 1985.
52. Solomon, A., Frangione, B. and Schiffer, M. Diagnostic, structural, and pathophysiological implications of

VI light chains in human amyloidosis AL. Clin. Res.
33 :561A, 1985.
53. Schiffer, M., Chang, C-H., Stevens, F.J. and Solomon, A. Implications of the protruding binding site of light-chain dimer LOC for the structure of the anti-idiotypic antibody. Proceedings of the
2 nd
Southwest Foundation for Biomedical Research Virology/Immunology Symposium , pp. 9,
1985.
54. Silvestris, F., Rots, N., Searles, R., Malone, C., Solomon, A., Yancy, W.B., and Williams, R.C., Jr.
Monoclonal antibodies to generic anti-idiotypes anti-F(ab')s recognize conformational epitopes on human light chains. Clin. Res.
38 :32A, 1990.
55. Solomon, A., Weiss, D.T., and Eulitz, M. Primary heavy chain-associated amyloidosis
(amyloidosis AH). Clin. Res.
38 :303A, 1990.
56. Wang, Q., Solomon, A., Weiss, D., Köhler, H., Pahwa, S., Tovo, P.-A., and Müller, S.
Preferential usage of V

1 light chains among human anti-gp-120 antibodies in HIV-1 infected individuals. The FASEB Journal, Abstracts Part I. 9 :A228, 1995.
57. Niewold, Th. A., Murphy, C.L., Wood, J., and Solomon, A. Immunoglobulin kappa light chain framework one (FR1) peptide is fibrillogenic. Abstracts of the FASEB Summer Research
Conference on: Amyloid and other abnormal protein assembly processes . Copper Mountain,
Colorado, 1995, pp. 40.
58. Wall, J.S., Niewold, Th. A., Murphy, C.L., and Solomon, A. Quantitation and characterisation of the binding of thioflavin T (THT) and Congo red (CR) to peptide fibrils. Abstracts of the FASEB
Summer Research Conference on: Amyloid and other abnormal protein assembly processes .
Copper Mountain, Colorado, 1995, pp. 58.
44

59. Murphy, C.L., Niewold, Th. A., and Solomon, A. Occurrence of prostaglandin D synthitase in urine of patients with immunoglobulin light chain amyloidosis (AL amyloidosis). Proc. of the
International Colloquium on ß-Trace
, Osaka (Japan), 1995, pp. 11.
60. Solomon, A. Light chain-associated conformational disease. International Workshop On
Conformational Diseases, Ein-Boqeq, Israel, 1998, pp.20.
61.
Hrncic, R., Wall, J., Schell, M., Macy, S.D., Wolfenbarger, D., Weiss, D.T., and Solomon, A.
Amyloidosis: antibody-mediated resolution of pathologic deposits. Blood.
94 : 4614, 1999.
62. Solomon, A. Extramedullary production of AL amyloid precursor protein. VII International
Multiple Myeloma Workshop. Stockholm, Sweden, 1999, pp.130.
63.
Solomon, A., Weiss, D.T., and Wall, J. Primary (AL) Amyloidosis: Recent discoveries regarding pathogenesis, diagnosis, and treatment. In Amyloid and Amyloidosis, In Amyloid and
Amyloidosis The Proceedings of the IXth International Symposium on Amyloidosis. Bély, M.,
Apáthy, Á. Eds. Hungary, 2001, pp. 256-262.
64.
Coriu, D., Murphy, C.L., Macy, S., Weaver, K., Schell, M., and Solomon,A. Transthyretin amyloidosis (ATTR) Thr60Ala (Appalachian) variant: a family study. In Amyloid and
Amyloidosis, The Proceedings of the IXth International Symposium on Amyloidosis. Bély, M.,
Apáthy, Á. Eds. Hungary, 2001, pp. 349-351.
65.
Hrncic, R., Wolfenbarger, D.A., Macy, S., Wooliver, C., Wall, J., Weiss, D.T., and Solomon, A.
Vaccine-based therapy for primary (AL) amyloidosis. In Amyloid and Amyloidosis, The
Proceedings of the IXth International Symposium on Amyloidosis. Bély, M., Apáthy, Á. Eds.
Hungary, 2001, pp. 234-235.
66.
Murphy, C.L., Williams, T.K., Weiss, D.T., and Solomon, A. A novel amyloid protein in calcifying epithelial odontogenic (Pindborg) tumor. In Amyloid and Amyloidosis, The
Proceedings of the IXth International Symposium on Amyloidosis. Bély, M., Apáthy, Á. Eds.
Hungary, 2001, pp. 422-423.
67.
Schell, M., Wall, J., Macy, S., Wooliver, C., Wolfenbarger, D.A., Weiss, D.T., and Solomon, A.
Prevention of AA amyloidosis by active immunotherapy. In Amyloid and Amyloidosis, The
Proceedings of the IXth International Symposium on Amyloidosis. Bély, M., Apáthy, Á. Eds.
Hungary, 2001, pp. 146-148.
68.
Wall, J., Schell, M., Hrncic, R., Macy, S., Wooliver, C., Wolfenbarger, C., Murphy, C., Donnell,
R., Weiss, D.T. and Solomon, A. Treatment of amyloidosis using an anti-fibril monoclonal antibody: pre-clinical efficacy in a murine model of AA-amyloidosis. In Amyloid and
Amyloidosis, The Proceedings of the IXth International Symposium on Amyloidosis. Bély, M.,
Apáthy, Á. Eds. Hungary, 2001, pp.158-160.
69.
Bergström, J., Murphy, C.L., Eulitz, M.,.Weiss, D.T., Westermark, G.T., Solomon, A., and
Westermark, P. Apolipoprotein A-IV co-deposited with transthyretin in senile systemic amyloidosis. In Amyloid and Amyloidosis, The Proceedings of the IXth International Symposium
45

on Amyloidosis. Bély, M., Apáthy, Á. Eds. Hungary, 2001, pp. 86-87
70.
Müller, D., Röcken, C., and Solomon, A. Localization of coagulation factor X in AL and AA amyloid. In Amyloid and Amyloidosis, The Proceedings of the IXth International Symposium on
Amyloidosis. Bély, M., Apáthy, Á. Eds. Hungary, 2001, pp. 279-280.
71.
Tang, L.X., Wolfenbarger, D., Williams, T., Weiss, D.T., and Solomon, A. Clinical importance of serum and urine free kappa and lambda light chain concentrations in primary (AL) amyloidosis.
In Amyloid and Amyloidosis, The Proceedings of the IXth International Symposium on
Amyloidosis. Bély, M., Apáthy, Á. Eds. Hungary, 2001, pp. 284-286.
72. Solomon, A., Weiss, D.T., and Wall, J.S. Therapeutic potential of amyloid-reactive monoclonal antibodies in primary (AL) amyloidosis. Multiple Myeloma, 9th International Workshop ,
Salamanca, Spain, 2003, pp.S261.
73. Murphy, C.L., Wang, S., Weaver, K., Williams, T.K., Gertz, M.A., Weiss, D.T., and Solomon, A.
Apolipoprotein A-I amyloidosis associated with a novel mutant. Xth International Symposium on
Amyloidosis . Tours, France, 2004, pp.71.
74. Solomon, A., Weiss, D.T., and Wall, J.S. Immunotherapy of AL amyloidosis.
Xth International
Symposium on Amyloidosis . Tours, France, 2004, pp.
75.
Murphy, C.L., Wang, S., Kestler, D.P., Macy, S.D., Williams, T.K., Carlson, E.R., Weiss, D.T., and Solomon, A. Pindborg tumor-associated amyloid proteins. Xth International Symposium on
Amyloidosis . Tours, France, 2004, pp.80.
76.
Wall, J.S., Kennel, S.J., Paulus, M.J., Gleason, S., Grogory, J., Wolfenbarger, D.A., Weiss, D.T., and Solomon, A. Radioimaging of primary (AL) amyloidosis with an amyloid-reactive monoclonal antibody. Xth International Symposium on Amyloidosis . Tours, France, 2004, p.43.
77.
Murphy, C.L., Crombie, B., Williams, T.K., Macy, S.D., Weiss, D.T., Solomon, A., and Nout,
Y.S. Systemic equine AL amyloidosis. Xth International Symposium on Amyloidosis . Tours,
France, 2004, pp.43.
78.
Wall, J.S., Murphy, C.L., Tomazewski, A., Crombie, B., and Solomon, A. Structural localization of light chain amyloidogenicity.
Xth International Symposium on Amyloidosis . Tours, France,
2004, pp.45.
79.
Murphy, C.L., Wang, S., Crombie, B., Macy, S.D., Williams, T.K., Weiss, D.T., and Solomon, A.
Medullary thyroid carcinoma-associated amyloid is comprised of calcitonin gene-related peptide
II.
Xth International Symposium on Amyloidosis . Tours, France, 2004, pp.78.
80.
Linke, R.P., Joswig, R., Murphy, C.L., Wang, S., Zhou, H., Gross, U., Röcken, C., Nathrath
W.B.J., Westermark, P., Weiss, D.T., and Solomon, A. Semenogelin I (Sgl) is the amyloidogenic
46

protein in senile seminal vesicle amyloid. Xth International Symposium on Amyloidosis . Tours,
France, 2004, pp.81.
81.
Gertz, M.A., Comenzo, R., Falk, R.H., Fermanci, J.P., Hazenberg, B.P., Hawkins, P.N., Merlini,
G., Moreau, P., Ronco, P., Sanchorawala, V., Sezer, O., Solomon, A., and Grateau, G. Definition of organ involvement and treatment response in primary systemic amyloidosis (AL): a consensus opinion from the 10 th
international symposium on amyloid and amyloidosis. Xth International
Symposium on Amyloidosis . Tours, France, 2004, pp.30.
82.
Wall, J.S., Kennel, S.J., Paulus, M.J., Gleason, S., Gregor, J., Schell, M., Smith, T., O’Nuallain,
B., Hawkins, P.N., and Solomon A. MicroSPECT/CT imaging of AA amyloidosis. Xth
International Symposium on Amyloidosis . Tours, France, 2004, pp.34.
83. O’Nuallain B., Murphy, C., Wolfenbarger, D., Kennel, S., Solomon, A., and Wall, J. The amyloidreactive monoclonal antibody 11-1F4 binds a cryptic epitope of fibrils and partially denatured immunoglobulin light chains and inhibits fibrillogenesis. Xth International Symposium on
Amyloidosis . Tours, France, 2004, pp.38.
84.
Bergström, J., Murphy, C., Solomon, A., Sletten, K., Hellman, U., and Westermark, P.
Apolipoprotein A-IV amyloidosis: a new form of systemic amyloidosis. Xth International
Symposium on Amyloidosis . Tours, France, 2004, pp.40.
85.
Ludlage, E., Murphy, C.L., Solomon, A., Weiss, D.T., Glenn-Smith, D., Dworkin, S., and
Mansfield, K.G. Systemic AA amyloidosis in the common marmoset. Xth International
Symposium on Amyloidosis . Tours, France, 2004, pp.58.
86. Yap, J.T., Wall, J.S., Kennel, S.J., Smith, A.M., Siegel, S.B., Solomon, A., and Townsend, D.W.
Improved visualization and quantification of small animal imaging with co-registered positron emission tomography/computed tomography and microPET. Mol. Imaging Biol.
7 :324, 2005.
87. Yap. J.T., Wall, J.S., Kennel, S.J., Solomon, A., and Townsend, D.W. Evaluation of [ 124 I]11-1F4, a novel positron emission tomography radiotracer for imaging systemic amyloid disease. Mol.
Imaging Biol.
7 :325, 2005.
88. Sletten, K., Wang, S., Murphy, C.L., Stevens, F.J., Weiss, D.T., and Solomon, A. Glycosylated amyloid and non-amyloid associated

light chains. XIth International Symposium on Amyloidosis .
Woods Hole, MA, in press.
89. Murphy, C.L., Wang, S., Williams, T.K., Weiss, D.T., and Solomon, A. Definitive identification of amyloid deposits by mass spectrometry. XIth International Symposium on Amyloidosis . Woods
Hole, MA, in press.
47

90. Macy, S.D., Williams, T.K., Wooliver, C., Murphy, C.L., Wang, S., Kestler, D., Westermark, P.,
Weiss, D.T., and Solomon, A. Apolipoprotein A-I (Apo A-I) nature of knee joint meniscusassociated amyloid. XIth International Symposium on Amyloidosis . Woods Hole, MA, in press.
91. Kestler, D.P., Hudson, J., Macy, S.D., Murphy, C.L., Wang, S., Foster, J.S., Weiss, D.T., and
Solomon, A. Detection and identification of amyloid deposition associated with human unerrupted tooth follicles. XIth International Symposium on Amyloidosis . Woods Hole, MA, in press.
92. Solomon, A., Weiss, D.T., Macy, S.D., Wooliver, C., and Westermark, P. Extramedullary production of AL amyloid precursor protein. XIth International Symposium on Amyloidosis .
Woods Hole, MA, in press.
93. Richey, T., Murphy, C.L., Wall, J.S., Westermark, G.T., Westermark, P. Weiss, D.T., and
Solomon, A. Foie gras is a dietary source of AEF. XIth International Symposium on Amyloidosis .
Woods Hole, MA, in press.
94. Weiss, D.T., Wooliver, C., and Solomon, A. Histochemical-based staging system for AL amyloidosis. XIth International Symposium on Amyloidosis . Woods Hole, MA, in press.
95. Williams, T.K., Macy, S.D., Wooliver, C., Murphy, C.L., Gorevic, P., Westermark, P., Weiss,
D.T., and Solomon, A. Localized AL amyloidosis: a distinctive clinicopathologic disorder. XIth
International Symposium on Amyloidosis . Woods Hole, MA, in press.
96. Donnell, R., Murphy, C.L., Eulitz, M., Williams, T.K., Macy, S.D., Weiss, D.T., and Solomon, A.
Odontogenic feline and canine tumor-associated amyloid is formed from ameloblastin. XIth
International Symposium on Amyloidosis . Woods Hole, MA, in press.
97. Wang, S., Murphy, C.L., Macy, S.D., Williams, T.K., Weiss, D.T., and Solomon, A. SAA
4
-related
AA amyloidosis. XIth International Symposium on Amyloidosis . Woods Hole, MA, in press.
98. Wooliver, C., Coriu, D., Murphy, C.L., Kestler, D., Wang, S., Weiss, D.T., and Solomon, A.
Familial amyloidosis associated with a novel mutation (D67G) in the lysozyme gene. XIth
International Symposium on Amyloidosis . Woods Hole, MA, in press.
99. Foster, J.S., Kestler, D.P., Murphy, C.L., Kennel, S.J., Wall, J.S., Weiss, D.T., and Solomon, A.
Amyloidogenic region of odontogenic ameloblast associated protein (ODAM). XIth International
Symposium on Amyloidosis . Woods Hole, MA, in press.
100. Eulitz, M., Murphy, C.L., Weiss, D.T., and Solomon, A. Role of light chain deamidation in the pathogenesis of AL amyloidosis. XIth International Symposium on Amyloidosis . Woods Hole,
MA, in press.
101. Landau, H., Comenzo, R.L., Zhou, P., Clark, B., Teruya-Feldstein, J., Wang, S., Murphy, C.L., and Solomon, A. AL amyloidosis in a patient with a T60A TTR mutation. XIth International
Symposium on Amyloidosis . Woods Hole, MA, in press.
48

102. Acero, L., Solomon, A., Wall, J.S., and O’Nuallain, B. Identification of novel inhibitors of light chain fibrillogenesis. XIth International Symposium on Amyloidosis . Woods Hole, MA, in press.
103. Davern, S.M., Murphy, C.L., Bohne, S., Wall, J.S., and Solomon, A. Modification of lysines on

Bence Jones proteins alters their ability to interact with human cells in vitro .
XIth International
Symposium on Amyloidosis . Woods Hole, MA, in press.
104. Allen, A., Kennel, S.J., Solomon, A., Wall, J.S., and O’Nuallain, B. Phage display and peptide epitope mapping of 11-1F4’s fibril-related conformational epitope. XIth International Symposium on Amyloidosis . Woods Hole, MA, in press.
105.
O’Nuallain, B., Allen, A., Richey, T., Wall, J.S., Weiss, D.T., and Solomon, A. Therapeutic potential of naturally occurring fibril-reactive human antibodies for AL amyloidosis. XIth
International Symposium on Amyloidosis . Woods Hole, MA, in press.
49